1. A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. Issue 6 (16th October 2020) Authors: Unseld, Matthias; Belic, Jelena; Pierer, Kerstin; Zhou, Qing; Moser, Tina; Bauer, Raimund; Piringer, Gudrun; Gerger, Armin; Siebenhüner, Alexander; Speicher, Michael; Heitzer, Ellen; Prager, Gerald W. Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. Issue 6 (16th October 2020) Authors: Unseld, Matthias; Belic, Jelena; Pierer, Kerstin; Zhou, Qing; Moser, Tina; Bauer, Raimund; Piringer, Gudrun; Gerger, Armin; Siebenhüner, Alexander; Speicher, Michael; Heitzer, Ellen; Prager, Gerald W. Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid. (July 2019) Authors: Kieler, Markus; Unseld, Matthias; Bianconi, Daniela; Scheithauer, Werner; Prager, Gerald W. Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Applied precision medicine in metastatic pancreatic ductal adenocarcinoma. (July 2020) Authors: Taghizadeh, Hossein; Müllauer, Leonhard; Mader, Robert M.; Schindl, Martin; Prager, Gerald W. Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer. (October 2020) Authors: Cardone, Claudia; Blauensteiner, Bernadette; Moreno-Viedma, Veronica; Martini, Giulia; Simeon, Vittorio; Vitiello, Pietro P.; Ciardiello, Davide; Belli, Valentina; Matrone, Nunzia; Troiani, Teresa; Morgillo, Floriana; Zito Marino, Federica; Dentice, Monica; Nappi, Annarita; Boccaccino, Alessandra... Journal: European journal of cancer Issue: Volume 138(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer. Issue 8 (31st July 2014) Authors: Prager, Gerald W.; Braemswig, Kira H.; Martel, Alexandra; Unseld, Matthias; Heinze, Georg; Brodowicz, Thomas; Scheithauer, Werner; Kornek, Gabriela; Zielinski, Christoph C. Journal: Cancer science Issue: Volume 105:Issue 8(2014:Aug.) Page Start: 996 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study. (January 2021) Authors: Prager, Gerald W.; Oehler, Leopold; Gerger, Armin; Mlineritsch, Brigitte; Andel, Johannes; Petzer, Andreas; Wilthoner, Klaus; Sliwa, Thamer; Pichler, Petra; Winder, Thomas; Heibl, Sonja; Gruenberger, Birgit; Laengle, Friedrich; Hubmann, Eva; Korger, Markus; Pecherstorfer, Martin; Djanani, Angela;... Journal: European journal of cancer Issue: Volume 143(2021) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma. Issue 7 (21st May 2020) Authors: Taghizadeh, Hossein; Zöchbauer‐Müller, Sabine; Mader, Robert M.; Müllauer, Leonhard; Klikovits, Thomas; Bachleitner‐Hofmann, Thomas; Hoda, Mir A.; Prager, Gerald W. Journal: Thoracic cancer Issue: Volume 11:Issue 7(2020) Page Start: 1979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients. Issue 5 (November 2015) Authors: Bianconi, Daniela; Schuler, Alexandra; Pausz, Clemens; Geroldinger, Angelika; Kaider, Alexandra; Lenz, Heinz-Josef; Kornek, Gabriela; Scheithauer, Werner; Zielinski, Christoph C.; Pabinger, Ingrid; Ay, Cihan; Prager, Gerald W. Journal: Thrombosis research Issue: Volume 136:Issue 5(2015) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform. (8th May 2020) Authors: Taghizadeh, Hossein; Mader, Robert M.; Müllauer, Leonhard; Aust, Stefanie; Polterauer, Stephan; Kölbl, Heinz; Seebacher, Veronika; Grimm, Christoph; Reinthaller, Alexander; Prager, Gerald W. Journal: Oncologist Issue: Volume 25:Number 7(2020) Page Start: e1060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗